Table 4.
IV (n = 146) | PO (n = 98) | p value | |
---|---|---|---|
LOS, days, median (IQR) | 10 (5–21) | 5 (4–6) | <0.01 |
30-day recurrence, n (%) | 3 (2.1) | 1 (1.0) | 0.65 |
30-day readmission, n (%) | 29 (19.9) | 15 (15.3) | 0.40 |
30-day all-cause mortality, n (%) | 6 (4.1) | 1 (1.0) | 0.25 |
Adverse reactions, n (%) | 2 (1.4) | 3 (3.1) | 0.39 |
IQR, interquartile range; IV, intravenous; LOS, length of stay; PO, oral.